We are live on ! Find out more
AC

Adelphi Capital Portfolio holdings

AUM $3.21M
1-Year Est. Return 121.6%
This Fund
S&P 500
This Quarter Est. Return
-19.38%
1 Year Est. Return
+121.6%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$417M
AUM Growth
-$107M
Cap. Flow
+$752K
Cap. Flow %
0.18%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
2
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$5.87M
2
FIS icon
Fidelity National Information Services
FIS
+$1.19M

Top Sells

Rank Stock Value
1
RYAAY icon
Ryanair
RYAAY
+$6.3M

Sector Composition

Rank Sector Weight
1 Technology 53.95%
2 Healthcare 33.82%
3 Industrials 12.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIS icon
1
Fidelity National Information Services
FIS
$22.3B
$225M 53.95%
1,848,079
+8,561
+0.5% +$1.19M
TAK icon
2
Takeda Pharmaceutical
TAK
$55.8B
$141M 33.82%
9,282,543
+323,759
+4% +$5.87M
RYAAY icon
3
Ryanair
RYAAY
$29.8B
$50.9M 12.23%
2,399,075
-200,068
-8% -$6.3M

Similar funds

TA
TA Associates Boston, Massachusetts $4.01M AUM 59.82% 1-Year Est. Return
TAM
Trikon Asset Management Hong Kong $1.84M AUM 172.11% 1-Year Est. Return
TMC
TVL Management Corporation Menlo Park, California $1.84M AUM 0.1% 1-Year Est. Return
AV
Arboretum Ventures Ann Arbor, Michigan $1.72M AUM 82.7% 1-Year Est. Return
MVPI
Maven Ventures Partners II Palo Alto, California $958K AUM 41.74% 1-Year Est. Return
RIA
RP Investment Advisors Toronto, Ontario, Canada $900K AUM 17.98% 1-Year Est. Return
IAC
ION Acquisition Corp Herzliya, Israel $5.63M AUM 38.71% 1-Year Est. Return
ALBM
Alcentra Ltd (BNY Mellon) London, United Kingdom $566K AUM 51.56% 1-Year Est. Return

Adelphi Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Adelphi Capital held 3 positions worth $417M, down 20% from $524M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Adelphi Capital opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 54% of assets, up from 49% a quarter earlier, followed by Healthcare and Industrials.

  • Adelphi Capital added most to Takeda Pharmaceutical in Q1 2020, an estimated $5.87M increase.
  • Adelphi Capital's biggest Q1 2020 reduction was Ryanair, cutting an estimated $6.3M.
  • Adelphi Capital's ten largest holdings make up 100% of its $417M portfolio in Q1 2020.
  • Adelphi Capital opened 0 new positions and closed 0 in Q1 2020.
  • Adelphi Capital's portfolio value fell 20% quarter-over-quarter to $417M.

Based on Adelphi Capital's 13F filing for Q1 2020, filed 14 Apr 2020.